The deals mean Glattbrugg-based Vifor claims a clinical-stage drug for patients with complications of end-stage chronic kidney disease (CKD), which has been taken into phase 3 by Sanifit, as well ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal. The Danish ...